Spanish Fly for two - how they affect libido in women and men
Contents Biologically active additive based on an extract obtained from a beetle with a fly (or fly...
Laboratory research methods occupy an important place in the diagnosis of cancer. ESR in oncology can increase tenfold and makes it possible to suspect a malignant process and carry out additional measures. The study contributes to early diagnosis, which is positively reflected in the further treatment of the patient. In order to correctly interpret the results of the examination, you need to know the indicators of the norm, changes and conditions that can increase the erythrocyte sedimentation rate.
Upon admission to the hospital, all patients undergo a blood test, including ESR.
The calculation of the rate of deposition of red shaped elements is carried out using Panchenkov. This is the most cost effective and fastest way. There are also methods of Westergren and Wintrob, which are used less frequently. In the laboratory, there are special devices designed to measure the speed of gluing shaped elements. To do this, take blood from a finger and 5% Na citrate. The components are mixed in a ratio of 1:4 and the process is monitored for 1 hour. After this time, the height of the column of accumulation of erythrocytes is determined. This is the meaning of ESR.
The erythrocyte sedimentation rate can be increased in healthy people, since it is sensitive to external and internal environmental factors. To minimize deviations, it is necessary to adhere to the following rules:
There is no single level of ESR that indicates the norm. It is different for adults and children, so you need to know the boundaries of the indicator for different categories of the population:
In women during pregnancy, ESR almost always rises and that is not considered a pathology. The reason for this phenomenon is the cardinal restructuring of the hormonal background, the activation of the activity of the cardiovascular and hematopoietic systems. The erythrocyte sedimentation rate in this category of the population should not exceed 30 mm/hour.
ESR in cancer is detected in a general blood test, which is included in the standard set of studies upon admission to inpatient treatment, with suspicion of infectious diseases. With the development of neoplasms, the following results are revealed:
The journal "Modern Oncology" published the results of a study confirming the absence of changes in ESR in the blood in oncology in 16-38% of the examined patients with cancer. These data confirm the need for additional diagnostics even with normal laboratory parameters.
In studies of venous material, indicators indicating oncology are also distinguished:
The erythrocyte sedimentation rate (ESR) changes significantly in the presence of oncology, which allows it to be detected in advance. Usually this indicator is determined during a clinical blood test.
Oncological pathology (cancer) is characterized by the appearance of foreign cells due to a failure in the genetic material and the formation of a malignant or benign tumor.
A malignant neoplasm has aggressive properties, is characterized by rapid cell reproduction, germination in tissues, and the ability to metastasize (daughter foci of neoplasm).
In tumor cells, the metabolism has significant differences; they synthesize a number of proteins that enter the bloodstream and change its physico-colloidal properties.
This leads to the fact that the ESR in cancer changes significantly - it becomes higher than the norm by 50-70 mm per hour or more.
A change in the indicator often occurs with the development of the following tumors:
The development of most benign neoplasms is not accompanied by changes in the ESR value. However, with erythremia (a benign pathology of the blood, in which the content of red blood cells and hemoglobin levels increase), there is a sharp decrease in the indicator.
Important! A high ESR that exceeds the norm is not always a sign of oncological pathology. It also changes in a number of infectious, endocrine diseases, after the use of certain medications. Therefore, for an accurate diagnosis of cancer according to indications determined by an oncologist, additional (clarifying) studies are prescribed, which include modern instrumental imaging techniques. These include CT, MRI, and ultrasound.
ESR is a diagnostic criterion that can be influenced by age and gender. An adult has a stable indicator, normally it remains the same, only with age the settling rate increases.
Normal indicators are presented in the table:
In order to get a reliable result of the study, it is very important to properly prepare for it.
To do this, follow a few simple recommendations:
Determination of the erythrocyte sedimentation rate refers to laboratory studies.
It is usually performed during clinical analysis or after venous blood sampling for biochemical profiling.
Today, in the laboratories of medical clinics, the determination of ESR is performed using 2 methods - according to and.
With this technique, blood is taken from the cubital vein. It is introduced into a special graduated test tube that contains an anticoagulant (a compound that prevents blood clotting, sodium citrate is usually used in laboratories).
After thorough mixing of venous blood and anticoagulant, the tube is left in a vertical position for 1 hour. Then, using a scale, the laboratory assistant evaluates the height of the plasma column, which shows the rate (the term reaction was previously used - ROE) of erythrocyte sedimentation.
Unlike the previous technique, blood is taken from a finger (capillary blood), which is pierced with a special scarifier.
Mixing with an anticoagulant is carried out in a test tube, after which blood is drawn into a special graduated glass capillary and placed in a tripod for an hour. Then the laboratory assistant evaluates the height of the plasma column above the settled erythrocytes on a scale. The result is displayed in units of mm/h.
Important! If you have an increase in ESR - do not panic. Even in the case of an established diagnosis of oncological pathology, in the early stages, the prognosis for human life remains favorable.
The effectiveness of cancer therapy depends on the timely detection of changes before the appearance of metastases in the lymph nodes or distant organs and tissues.
The patient may not even guess about the malignant neoplasm that has arisen in the body for a long time. As a rule, this "terrible" pathology at first develops asymptomatically, and this is its insidiousness. The presence of a malignant tumor and its progression are evidenced by changes in the blood test, including deviations from the norm of the ESR indicator.
The rate of erythrocyte sedimentation in the blood normally depends not only on the gender of the patient, but also on age. Its deviations in the direction of decrease or increase indicate the processes of disharmony in the body, not necessarily in the direction of the disease. In particular, it can be hormonal disruptions, menstrual cycles in women, pregnancy, the postpartum period.
The established norms for the level of erythrocyte sedimentation are:
An increased erythrocyte sedimentation rate is considered a cause for concern if it rises significantly in comparison with the established norms.
A slight increase in the ESR in women, as a rule, does not alarm specialists, since it directly depends on the state of hormonal metabolism, which is often disturbed while taking hormonal contraceptives, during menopause, during pregnancy.
An increased ESR can be considered a sign of many diseases of an inflammatory and chronic nature, while the clinical picture of the blood has an altered composition in other parameters. In particular, ESR in oncology increases markedly against the background of an equally noticeable decrease in the amount of hemoglobin.
Experts can suspect the occurrence and development of a malignant neoplasm in the body in the case of:
ESR rises already at the first "asymptomatic" stage of cancer, so often this analysis helps to timely identify cancerous pathology and take therapeutic measures in time.
The changed level of the clinical indicator of the erythrocyte sedimentation rate in the blood prompts specialists to search for an acute inflammatory pathology in the body. If it cannot be detected, then there is a reason for suspicion of cancerous pathologies. As a rule, high ESR values are diagnosed:
By themselves, indicators of the rate of sedimentation of red blood cells are not one hundred percent evidence of oncological pathology, and more often it is used to track the dynamics of the progression of the tumor process in cancer.
Since the analysis involves the determination of many indicators, its decoding helps answer a number of important diagnostic questions:
Their ratio helps to determine the place of possible localization of tumor pathology:
Despite the high degree of informativeness of the general analysis of blood composition, doctors are not recommended to focus only on these data when making a diagnosis. Some very serious pathologies do not fit into the clinical scheme and are difficult to diagnose using tests:
If the patient has an established oncological diagnosis, an analysis of the ESR content will help to effectively monitor the dynamics of the tumor process and help to understand in time whether the drugs for tumor therapy are selected correctly. Control is especially important in oncology of the lungs and intestines, since there is a risk of the tumor moving into a latent stage.
With constant monitoring of the erythrocyte sedimentation rate, the doctor gets the opportunity to control the dynamics of the tumor process: with inhibition of growth and progression of cancer, its indicators decrease, and during the period of exacerbation they increase sharply.
It is important to pay attention to the fact that high rates of erythrocyte sedimentation do not indicate the mandatory development of the tumor process. Even if all three components converge in the analysis - ESR, hemoglobin, leukocyte formula - this will only serve as a reason for a detailed additional study.
Ordinary healthy cells of the human body divide quite slowly, so they are not so susceptible to inhibition by cytostatics - drugs for chemotherapy.
But this does not apply to bone marrow cells that have a hematopoietic function. They divide as rapidly as malignant cells, and therefore are destroyed by therapy due to the rapid rate of division.
Chemotherapy has serious side effects for the human hematopoietic system. The blood of the patient after the course of chemotherapy sharply becomes poorer in its composition. This condition of the patient is called myelosuppression or pancytopenia - a sharp decrease in the blood of all its elements due to impaired hematopoietic function. This applies to the level of leukocytes, platelets, erythrocytes and so on in the blood plasma.
Through the blood flow, chemotherapy drugs spread throughout the body and at their end points - the foci of malignant tumors - have a devastating effect on cancer cells. But the blood elements themselves, which become damaged, are exposed to the same effect.
ESR is an indicator of the rate of erythrocyte sedimentation in the blood, which can be determined during a general blood test. In deciphering the data on the state of the patient's blood, the last digit will indicate the level of ESR.
The analysis is carried out as follows: a substance is added to the blood that prevents its clotting, and the test tube is left in an upright position for an hour. Gravity forces the erythrocytes to settle to the bottom of the tube. After that, the height of the blood plasma of a transparent yellow color, which was formed within an hour, is measured - it no longer contains red blood cells.
After chemotherapy, the patient's ESR is increased, since a reduced number of red blood cells is observed in the blood, which is due to damage to the patient's hematopoietic system and pronounced anemia.
Lymphocytes are one of the groups of leukocytes and serve to recognize agents harmful to the body and neutralize them. They are produced in the human bone marrow, and actively function in the lymphoid tissue.
The patient's condition after chemotherapy is characterized by the so-called lymphopenia, which is expressed in a decrease in lymphocytes in the blood. With an increase in the dose of chemotherapy, the number of lymphocytes in the blood drops dramatically. At the same time, the patient's immunity also deteriorates, which makes the patient unprotected to infectious diseases.
Leukocytes are white blood cells, which include cells of different appearance and functions - lymphocytes, monocytes, neutrophils, eosinophils, basophils. First of all, in the human body, leukocytes represent a protective function against pathogenic agents that are of external or internal origin. Therefore, the work of leukocytes is directly related to the level of human immunity and the state of the protective capabilities of his body.
The level of leukocytes in the blood after the course of chemotherapy was sharply reduced. This condition is dangerous for the human body as a whole, since the patient's immunity falls, and the person becomes exposed to even the simplest infections and harmful microorganisms. The resistance of the patient's body is greatly reduced, which can provoke a sharp deterioration in health.
Therefore, a necessary measure after undergoing chemotherapy is to increase the level of leukocytes in the blood.
After a course of chemotherapy in the patient's blood, there is a sharp decrease in the number of platelets, which is called thrombocytopenia. This condition of the blood after the transferred treatment is dangerous for the health of the patient, since platelets affect blood clotting.
The use of dactinomycin, mutamivin, and nitrosourea derivatives in chemotherapy has a very strong effect on platelets.
A decrease in the number of platelets in the blood is manifested in the appearance of bruises on the skin, bleeding from the mucous membranes of the nose, gums, and digestive tract.
Treatment of thrombocytopenia is selected depending on the severity of the disease. Low and medium degree of the disease does not require special treatment. But a severe degree of the disease, life-threatening, requires the use of a platelet transfusion. With a reduced level of platelets in the blood, the next course of chemotherapy may be delayed or the doses of drugs may be reduced.
To increase the level of platelets in the blood, you need to resort to certain measures:
The consequences of chemotherapy is the inhibition of hematopoiesis, that is, the function of hematopoiesis, which also applies to the production of red blood cells. The patient has erythrocytopenia, which manifests itself in a low number of red blood cells in the blood, as well as a drop in hemoglobin levels, as a result of which anemia develops.
The level of hemoglobin in the blood becomes critical, especially after repeated courses of chemotherapy, as well as with a combination of chemotherapy and radiation therapy.
An increase in hemoglobin levels after a course of chemotherapy means an increase in the chances of patients to recover. Since the level of hemoglobin in the blood directly affects the survival of cancer patients.
Anemia is a sharp decrease in the number of red blood cells - erythrocytes, as well as hemoglobin - a protein found in erythrocytes. All cancer patients have mild or moderate anemia after undergoing chemotherapy. Some patients experience severe anemia.
As mentioned above, the cause of anemia is the inhibition of the functioning of the hematopoietic organs, damage to blood cells, which negatively affects the blood formula and its composition.
Anemia symptoms are:
Anemia in cancer patients after chemotherapy can last for years, which requires the adoption of effective measures for its treatment. Mild and moderate anemia does not require enhanced therapy - it is enough to change the diet and take drugs that improve blood composition. In severe anemia, it is necessary to resort to a blood or red blood cell transfusion, as well as other measures. This was discussed in detail in the sections on increasing the level of red blood cells and hemoglobin.
ALT - alanine aminotransferase - is a special protein (enzyme), which is located inside the cells of the human body, involved in the exchange of amino acids that make up proteins. ALT is present in the cells of certain organs: in the liver, kidneys, muscles, heart (in the myocardium - the heart muscle) and pancreas.
AST - aspartate aminotransferase - is a special protein (enzyme), which is also located inside the cells of certain organs - the liver, heart (in the myocardium), muscles, nerve fibers; in a smaller amount it contains the lungs, kidneys and pancreas.
Elevated levels of ALT and AST in the blood indicate the presence of a moderate or high degree of damage to the organ containing this protein. After a course of chemotherapy, there is an increase in the amount of liver enzymes - ALT and AST - in the blood serum. These changes in the results of laboratory tests mean, first of all, toxic damage to the liver.
Chemotherapy drugs have a depressing effect not only on the bone marrow, but also on other hematopoietic organs - the spleen and so on. And the larger the dose of drugs, the more noticeable the results of damage to internal organs become, and the function of hematopoiesis is more strongly inhibited.
Cancer patients often ask themselves: how to increase white blood cells after chemotherapy?
There are several common ways, which include:
Patients after a course of chemotherapy are puzzled by the question: how to increase hemoglobin after chemotherapy?
You can increase your hemoglobin level in the following ways:
Erythrocytes are shaped elements of the blood that are not cells in the full sense of the word. They do not have nuclei (this device arose in order to accommodate more hemoglobin with the same volume of red blood cells). The main function of erythrocytes is transport of oxygen to every cell of the body and carbon dioxide in the opposite direction.
Since erythrocytes contain many different substances that are heavier than water, their density is greater than the density of blood plasma, and therefore, over time, erythrocytes settle if the blood does not move and mix. At various diseases the density of erythrocytes and blood plasma changes, and at the same time, the erythrocyte sedimentation rate (ESR) also changes. By these changes, it is possible to determine what exactly a person fell ill with.
For research, they usually take venous blood (although capillary blood is also possible). Special substances are added to the blood that help separate red blood cells from blood plasma and prevent blood clotting. Then the blood is left in the test tube for an hour and they look at how many millimeters the erythrocyte sedimentation occurred during this time.
Of course, it is impossible to see individual erythrocytes, but it is they who create the red color of the blood, and when they settle on top, a transparent layer of plasma is formed, where there are no more erythrocytes.
The norms of erythrocyte sedimentation rate can vary greatly in different categories of people. There is a clear relationship between ESR and age, ESR and gender. Consider the erythrocyte sedimentation rate in individuals of various categories.
Tab. 1. Erythrocyte sedimentation rate in individuals of various categories.
As you can see, the ESR norm can vary greatly depending on the age and sex of the person. Another reason that can accelerate the erythrocyte sedimentation rate is pregnancy. The fact is that during pregnancy, the content of proteins that enter the blood plasma changes in the blood, and this leads to the fact that red blood cells begin to settle faster.
Noticeable changes begin only in the fourth month, and increase by the ninth.
Thus, if in the first trimester the speed is about 15 mm / h, in the second - 25, and in the third - already forty.
In oncological diseases, a sharp increase in the erythrocyte sedimentation rate occurs. Typically, the settling rate increases by 70-80 millimeters per hour, that is, several times.
At the same time, a similar reaction can occur in the body to any inflammatory process, and therefore a simple increase in ESR is not a sign by which cancer can be diagnosed.
Therefore, if the ESR has increased, the person is sent for additional examination in order to find out what exactly caused the increase: cancer or simple inflammation.
Most often due to a change in ESR and subsequent follow-up examination detect such cancers:
There are cases of detection of other forms of cancer in this analysis with subsequent additional examination, but less frequently.
As you know, in addition to malignant tumors, there are also benign tumors. They grow more slowly than malignant ones, or stop their growth altogether, but can press on neighboring organs, disrupting their activity. Under certain conditions, benign tumors turn into malignant ones.
At the same time, benign tumors also increase the erythrocyte sedimentation rate, which can cause unjustified anxiety for the patient, who will suspect cancer after learning about the results. It should be understood that a benign tumor can exist for decades and decades to affect the ESR without degenerating into a malignant tumor.
So, elevated ESR does not always mean cancer. Who else has this symptom? The erythrocyte sedimentation rate is increased with anemia(anemia) with normal erythrocyte morphology.
With anemia, the ratio of plasma and formed elements changes, and the erythrocytes settle with the formation of characteristic columns that an experienced specialist can distinguish.
There is an increase in ESR with kidney failure. At the same time, the level fibrinogen protein, which is provided by changes in the erythrocyte sedimentation rate. This mechanism of increasing ESR is also found in obesity to an extreme degree.
Blood in women in general and in pregnant women in particular, as well as in the elderly, erythrocytes in the blood also settle faster, as mentioned above. In addition, the rate of erythrocyte sedimentation may be higher due to laboratory error during the analysis.
The erythrocyte sedimentation rate decreases with a change in the morphology (external structure) of erythrocytes, an increase in the number of leukocytes (white blood cells), with an increase in the amount of bile salts in the blood plasma, during breastfeeding.
Since cancer lesions of various organs can lead to both an increase in the number of leukocytes and an increase in the amount of bile in the blood (this is cancer of the bone marrow and liver, respectively), it turns out that oncological disease gives two opposite effects that compensate for each other. Thus, the increase in the rate of erythrocyte sedimentation in cancer may be lower than expected.
The use of various substances can affect the results of the analysis. For example, dextran, some hormonal contraceptives, vitamin A, and the hepatitis vaccine increase ESR.
Valproic acid, cortisone, glucose, fluorides, quinine can reduce this figure. That is why before the analysis you need to say that you took certain drugs. It is possible that the analysis will have to be postponed, since it is impossible to obtain a reliable result while these substances remain in the blood.
In addition to ESR, cancer affects the level of hemoglobin. With cancer of the stomach or intestines, the level of hemoglobin decreases, with cancer of other organs, too, but not so noticeably. In bone marrow cancer, a drop in hemoglobin levels can be observed with a decrease in the number of platelets and the rate of blood clotting.
Cancer cells also produce special substances that are not produced in healthy cells. These substances are called tumor markers, and it is their presence that is a serious indication of the presence of an oncological disease.
Moreover, it is almost impossible to determine brain cancer in this way, so it is not always possible to detect the disease with the help of tumor markers.
In order for the analysis to show the correct result, you need to follow a few simple recommendations: do not eat 8 hours before the analysis (that is, donate blood in the morning without breakfast), stop using it for 1-2 days alcohol, fried foods, and foods that are high in fat. Do not smoke for a couple of hours before the analysis.
If you use any medications at the time of the test, you need to tell the doctor about it, because medications can also affect the result.
Anyone who does not follow the rules for preparing for analysis runs the risk of getting an underestimated or overestimated result, which will result in suspicions of a serious illness and unnecessary worries.
Thus, the erythrocyte sedimentation rate is an indicator that does not remain in a person all his life, but changes over time, depending on age and state of the body. Of course, a speed increased by 60-70 units can be a sign of cancer, but not necessarily, because it could also change due to an inflammatory process, poisoning, or other reasons.
ESR also increases with the development of benign neoplasms. Therefore, there is no need to panic in case of an increase in ESR, instead, other tests should be taken and, based on their results, we should already talk about the diagnosis.